HIGHOutside partyCustomer
74%
international distributors
“10-K Item 1A: 'International distributors accounted for approximately 74% of international revenues for the fiscal year ended May 31, 2025.'”
ANGO · Concentration risk · 10-K extracted
AngioDynamics (ANGO) concentration risks
Updated
The most significant concentration AngioDynamics discloses is international distributors at 74%, classified HIGH by disclosed size. Below: the full set from the latest 10-K — verbatim quotes, filing references, and a synthesis of what these exposures mean together.
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Source: AngioDynamics’s SEC Form 10-K filed — view the filing on SEC EDGAR ↗
At a glance
Disclosed-size breakdown · 3 disclosed concentrations
HIGH2
MEDIUM1
LOW0
Disclosed concentrations
Each card carries a disclosed-size chip (HIGH / MEDIUM / LOW — how large the exposure is as a share of revenue, not how dangerous it is) and a nature tag: Built-in(the company’s own model, geography, or products) or Outside party (an external customer, supplier, or distributor it relies on).
HIGHOutside partySupplier
single and limited source suppliers
“10-K Item 1A: 'We are dependent on single and limited source suppliers which subjects our business and results of operations to risks of supplier business interruptions.'”
MEDIUMOutside partyCustomer
GPO and IDN contracts
“10-K Item 1A: 'sales through a GPO or IDN can be significant to our business and our inability to retain contracts with our customers, or acquire additional contracts, could have a material adverse effect on our business, financial condition, results of operations and/or liquidity.'”
TrendMatrix Research · concentration synthesis
What these concentrations mean together
updated 2026-07-06AngioDynamics carries concentration risk on both the distribution and supply sides of its business, plus a contract-based customer channel. International distributors accounted for approximately 74% of international revenues for the fiscal year ended May 31, 2025 — a high-share dependency on a narrow set of distribution partners outside the U.S. On the supply side, the company is dependent on single and limited source suppliers, which subjects the business to risks of supplier interruptions, another high-share dependency. Layered alongside these is a medium-share dependency on group purchasing organization (GPO) and integrated delivery network (IDN) contracts, where sales through these channels can be significant and losing or failing to renew such contracts could have a material adverse effect. None of these three exposures are structural; all stem from specific counterparty relationships that could, in principle, be diversified over time. Taken together, the two high-share dependencies — international distribution and supplier concentration — are the more consequential exposures, since a disruption on either side would directly constrain the company's ability to manufacture and sell product, while the GPO/IDN contract risk is a secondary but still material channel dependency.
For the engine’s reasoning on ANGO’s current verdict — including which dimensions drove the score — see the per-dimension breakdown.
Industry peers · Medical Instruments & Supplies
Peer concentration profile
| Symbol | Name | HIGH | MEDIUM | LOW | Total |
|---|---|---|---|---|---|
| ANGO● | AngioDynamics, Inc. | 2 | 1 | 0 | 3 |
| ATRC | AtriCure, Inc. | 1 | 1 | 1 | 3 |
| ATR | AptarGroup, Inc. | 1 | 1 | 0 | 2 |
| ALGN | Align Technology, Inc. | 1 | 0 | 0 | 1 |
| AVR | Anteris Technologies Global Cor | 1 | 0 | 0 | 1 |
| AVTR | Avantor, Inc. | 1 | 0 | 0 | 1 |
Concentration counts reflect items disclosed in each peer’s most recent 10-K; disclosed-size classification uses TrendMatrix’s internal 10-K extraction taxonomy.